Literature DB >> 2398539

Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

E Malvoisin1, F Wild.   

Abstract

To study the contribution of the measles virus fusion (F) protein in the immune response, anti-F monoclonal antibodies were prepared by using a vaccinia-measles virus F recombinant. In contrast to previously described anti-F monoclonal antibodies, these antibodies not only neutralized virus infectivity and inhibited fusion but also passively protected mice. Since these monoclonal antibodies recognize a configurational epitope, presentation of the antigen during infection may play an important role in the immune response. These factors are discussed in relation to vaccination.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2398539      PMCID: PMC248009     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies.

Authors:  H Sheshberadaran; E Norrby; K C McCullough; W C Carpenter; C Orvell
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

2.  A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein.

Authors:  A C Samson; M M Willcocks; E G Routledge; L A Morgan; G L Toms
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

3.  Measles vaccination. 3. Serologic responses to immunization with purified hemagglutinin.

Authors:  E Norrby; R Lagercrantz; S Gard; G Carlström
Journal:  Acta Paediatr Scand       Date:  1965-11

4.  Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene.

Authors:  T Yilma; D Hsu; L Jones; S Owens; M Grubman; C Mebus; M Yamanaka; B Dale
Journal:  Science       Date:  1988-11-18       Impact factor: 47.728

5.  Isolation and characterization of subacute sclerosing panencephalitis virus (Yamagata-1 strain) from a brain autopsy.

Authors:  M Homma; M Tashiro; H Konno; Y Ohara; M Hino; S Takase
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

6.  Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.

Authors:  E Norrby; G Enders-Ruckle; V Meulen
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

7.  Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

8.  Monoclonal antibodies against measles virus.

Authors:  P Giraudon; T F Wild
Journal:  J Gen Virol       Date:  1981-06       Impact factor: 3.891

9.  Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity.

Authors:  P Giraudon; T F Wild
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

Review 10.  Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection.

Authors:  D C Merz; A Scheid; P W Choppin
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  28 in total

1.  Measles virus glycoprotein complexes preassemble intracellularly and relax during transport to the cell surface in preparation for fusion.

Authors:  Melinda A Brindley; Sukanya Chaudhury; Richard K Plemper
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.

Authors:  S F Atabani; O E Obeid; D Chargelegue; P Aaby; H Whittle; M W Steward
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Recombinant nipah virus vaccines protect pigs against challenge.

Authors:  Hana M Weingartl; Yohannes Berhane; Jeff L Caswell; Sheena Loosmore; Jean-Christophe Audonnet; James A Roth; Markus Czub
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization.

Authors:  J Fayolle; B Verrier; R Buckland; T F Wild
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.

Authors:  F Bouche; W Ammerlaan; F Berthet; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

6.  Mechanism for active membrane fusion triggering by morbillivirus attachment protein.

Authors:  Nadine Ader; Melinda Brindley; Mislay Avila; Claes Örvell; Branka Horvat; Georg Hiltensperger; Jürgen Schneider-Schaulies; Marc Vandevelde; Andreas Zurbriggen; Richard K Plemper; Philippe Plattet
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

7.  Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein.

Authors:  R S van Binnendijk; J P Versteeg-van Oosten; M C Poelen; H F Brugghe; P Hoogerhout; A D Osterhaus; F G Uytdehaag
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.

Authors:  Chien-Hsiung Pan; Nitya Nair; Robert J Adams; M Christine Zink; Eun-Young Lee; Fernando P Polack; Manmohan Singh; Derek T O'Hagan; Diane E Griffin
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

9.  CD4+ T cells control measles virus infection of the central nervous system.

Authors:  A Reich; O Erlwein; S Niewiesk; V ter Meulen; U G Liebert
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

10.  Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice.

Authors:  M Jeff Bergen; Chien-Hsiung Pan; Catherine E Greer; Harold S Legg; John M Polo; Diane E Griffin
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.